The role of IGFs in catabolism

被引:27
作者
Botfield, C [1 ]
Ross, RJM
Hinds, CJ
机构
[1] Univ London St Bartholomews Hosp Med Coll, Dept Intens Care, London EC1A 7BE, England
[2] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
来源
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM | 1997年 / 11卷 / 04期
关键词
insulin-like growth factor-1; insulin-like growth factor-2; carrier proteins; growth hormone; catabolism; critical illness; anabolic therapy;
D O I
10.1016/S0950-351X(97)80958-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hypercatabolic response to trauma, extensive surgery and sepsis is characterized by an increased metabolic rate, severe muscle wasting and a negative nitrogen balance. This process of 'autocannibalism' may be in part a consequence of a disordered growth hormone (GH)/insulin-like growth factor (IGF) axis. In this chapter the normal physiology of the GH/IGF axis is first briefly reviewed. This is followed by a discussion of the changes that accompany fasting and catabolic illness, the effects of IGF-1 administration in health and disease and a comparison of the effects of IGF-1, GH and insulin on catabolism. Although initial investigations of IGF-1 administration in animals and human volunteers have often been encouraging, studies in catabolic patients have so far proved disappointing. Combined treatment with GH, IGF-1 (and insulin) or with IGF-I and its major binding protein, may prove more effective, especially when used in conjunction with nutritional supplements such as glutamine.
引用
收藏
页码:679 / 697
页数:19
相关论文
共 110 条
[1]  
ADAMO M, 1992, BIOFACTORS, V3, P151
[2]   Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - A clinical research center study [J].
Backeljauw, PF ;
Underwood, LE ;
Miras, M ;
Arriazu, MC ;
Heinrich, J ;
Ghizzoni, L ;
Blethen, S ;
Donaldson, D ;
Cleveland, W ;
Duncan, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3312-3317
[3]  
Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0
[4]   CIRCULATING BINDING-PROTEINS FOR THE INSULIN-LIKE GROWTH-FACTORS [J].
BAXTER, RC .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (03) :91-96
[5]  
BEMEIS K, 1996, CLIN NUTR, V44, P525
[6]   THE ROLE OF INSULIN-LIKE GROWTH FACTOR-I IN GROWTH OF DIABETIC RATS [J].
BINZ, K ;
ZAPF, J ;
FROESCH, ER .
ACTA ENDOCRINOLOGICA, 1989, 121 (05) :628-632
[7]   IN-VIVO PROTEOLYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 RESULTS IN INCREASED AVAILABILITY OF IGF TO TARGET-CELLS [J].
BLAT, C ;
VILLAUDY, J ;
BINOUX, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2286-2290
[8]  
BLUM WF, 1993, GROWTH REGULAT, V3, P100
[9]  
BLUM WR, 1990, ACTA PAEDIATR SCAND, V367, pS55
[10]   DIVERSE EFFECTS OF INSULIN-LIKE GROWTH-FACTOR I ON GLUCOSE, LIPID, AND AMINO-ACID-METABOLISM [J].
BOULWARE, SD ;
TAMBORLANE, WV ;
MATTHEWS, LS ;
SHERWIN, RS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (01) :E130-E133